Advanced search
1 file | 1.14 MB Add to list

The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium

Lynn Ghijselings (UGent) , Dirk Van de Putte (UGent) , François Hervé (UGent) , An-Sofie Goessaert (UGent) , Dimitri Beeckman (UGent) , Piet Pattyn (UGent) and Karel Everaert (UGent)
(2020) ACTA CLINICA BELGICA. 75(5). p.334-339
Author
Organization
Abstract
Introduction/Background: The management of therapy-resistant lower urinary tract symptoms (LUTS) and symptoms resulting from pelvic organ dysfunctions are subject to a high variability in the Belgian health-care centres. Practical guidelines and standardized patient clinical care pathways are often lacking and unadapted to the Belgian healthcare system. Objectives: The OptiLUTS trial aims to improve the multidisciplinary care of therapy-resistant symptoms of the pelvis in the Belgian healthcare setting. Project A aims for the improvement of knowledge of 2nd line treatments for LUTS among general practitioners. In project B a treatment algorithm for the overactive bladder syndrome and non-obstructive urinary retention will be developed specifically for Belgium. In Project C a patient customized sacral neuromodulation (SNM) care pathway will be set up. Methods: Part A: Explorative study among general practitioners by distribution of a questionnaire. Part B: Review of existing guidelines and use of the Delphi method to obtain expert consensus. Part C: A single center comparative study to compare outcomes before and after implementation of the SNM care pathway. Patients scheduled for the first stage of Interstim therapy (TM) will be included (N=100). Primary endpoints are the sensitivity and specificity of a new pelvic symptom assessment tool, the conversion to implant and explantation rates. Conclusion: There is a margin for improvement in the care process of patients with therapy-resistant symptoms of the pelvis in the Belgium healthcare system. In the OptiLUTs trial adapted guidelines and a clinical care pathway will be developed to standardize and increase the efficiency of care.
Keywords
General Medicine, Lower urinary tract symptoms, Clinical care pathway, Sacral neuromodulation, Overactive bladder, Quality Improvement, QUALITY-OF-LIFE, SACRAL NEUROMODULATION, SCORING SYSTEM, QUESTIONNAIRE, IMPACT, INDEX, ICIQ

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.14 MB

Citation

Please use this url to cite or link to this publication:

MLA
Ghijselings, Lynn, et al. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA, vol. 75, no. 5, 2020, pp. 334–39, doi:10.1080/17843286.2019.1630109.
APA
Ghijselings, L., Van de Putte, D., Hervé, F., Goessaert, A.-S., Beeckman, D., Pattyn, P., & Everaert, K. (2020). The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium. ACTA CLINICA BELGICA, 75(5), 334–339. https://doi.org/10.1080/17843286.2019.1630109
Chicago author-date
Ghijselings, Lynn, Dirk Van de Putte, François Hervé, An-Sofie Goessaert, Dimitri Beeckman, Piet Pattyn, and Karel Everaert. 2020. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA 75 (5): 334–39. https://doi.org/10.1080/17843286.2019.1630109.
Chicago author-date (all authors)
Ghijselings, Lynn, Dirk Van de Putte, François Hervé, An-Sofie Goessaert, Dimitri Beeckman, Piet Pattyn, and Karel Everaert. 2020. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA 75 (5): 334–339. doi:10.1080/17843286.2019.1630109.
Vancouver
1.
Ghijselings L, Van de Putte D, Hervé F, Goessaert A-S, Beeckman D, Pattyn P, et al. The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium. ACTA CLINICA BELGICA. 2020;75(5):334–9.
IEEE
[1]
L. Ghijselings et al., “The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium,” ACTA CLINICA BELGICA, vol. 75, no. 5, pp. 334–339, 2020.
@article{8669635,
  abstract     = {{Introduction/Background: The management of therapy-resistant lower urinary tract symptoms (LUTS) and symptoms resulting from pelvic organ dysfunctions are subject to a high variability in the Belgian health-care centres. Practical guidelines and standardized patient clinical care pathways are often lacking and unadapted to the Belgian healthcare system.
Objectives: The OptiLUTS trial aims to improve the multidisciplinary care of therapy-resistant symptoms of the pelvis in the Belgian healthcare setting. Project A aims for the improvement of knowledge of 2nd line treatments for LUTS among general practitioners. In project B a treatment algorithm for the overactive bladder syndrome and non-obstructive urinary retention will be developed specifically for Belgium. In Project C a patient customized sacral neuromodulation (SNM) care pathway will be set up.
Methods: Part A: Explorative study among general practitioners by distribution of a questionnaire. Part B: Review of existing guidelines and use of the Delphi method to obtain expert consensus. Part C: A single center comparative study to compare outcomes before and after implementation of the SNM care pathway. Patients scheduled for the first stage of Interstim therapy (TM) will be included (N=100). Primary endpoints are the sensitivity and specificity of a new pelvic symptom assessment tool, the conversion to implant and explantation rates.
Conclusion: There is a margin for improvement in the care process of patients with therapy-resistant symptoms of the pelvis in the Belgium healthcare system. In the OptiLUTs trial adapted guidelines and a clinical care pathway will be developed to standardize and increase the efficiency of care.}},
  author       = {{Ghijselings, Lynn and Van de Putte, Dirk and Hervé, François and Goessaert, An-Sofie and Beeckman, Dimitri and Pattyn, Piet and Everaert, Karel}},
  issn         = {{1784-3286}},
  journal      = {{ACTA CLINICA BELGICA}},
  keywords     = {{General Medicine,Lower urinary tract symptoms,Clinical care pathway,Sacral neuromodulation,Overactive bladder,Quality Improvement,QUALITY-OF-LIFE,SACRAL NEUROMODULATION,SCORING SYSTEM,QUESTIONNAIRE,IMPACT,INDEX,ICIQ}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{334--339}},
  title        = {{The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium}},
  url          = {{http://dx.doi.org/10.1080/17843286.2019.1630109}},
  volume       = {{75}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: